Oncología médica
Specialty
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublications in collaboration with researchers from Ikerbasque, Fundación Vasca para la Ciencia (34)
2024
-
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer
Breast Cancer Research, Vol. 26, Núm. 1
-
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant eR+ breast cancer
Science Translational Medicine, Vol. 16, Núm. 736
-
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms
Pathology, Vol. 56, Núm. 4, pp. 493-503
-
Power of Light: Raman Spectroscopy and Machine Learning for the Detection of Lung Cancer
ACS Omega, Vol. 9, Núm. 12, pp. 14084-14091
2023
-
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
Nature Communications, Vol. 14, Núm. 1
2022
-
Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)
Scientific Reports
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Journal of Clinical Investigation, Vol. 132, Núm. 7
2021
-
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)
British Journal of Cancer
-
Discovery and proof-of-concept study of nuclease activity as a novel biomarker for breast cancer tumors
Cancers, Vol. 13, Núm. 2, pp. 1-16
-
Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma
Cancers, Vol. 13, Núm. 2, pp. 1-23
-
Integrated mrna and mirna transcriptomic analyses reveals divergent mechanisms of sunitinib resistance in clear cell renal cell carcinoma (Ccrcc)
Cancers, Vol. 13, Núm. 17
-
The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer
Cancers, Vol. 13, Núm. 21
2020
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
Scientific Reports, Vol. 10, Núm. 1
-
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
International Journal of Cancer, Vol. 147, Núm. 5, pp. 1315-1324
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2019
-
Liquid biopsy in glioblastoma: Opportunities, applications and challenges
Cancers, Vol. 11, Núm. 7
-
Therapeutic relevance of SOX9 stem cell factor in gastric cancer
Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 2, pp. 143-152